SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-028198
Filing Date
2022-08-10
Accepted
2022-08-10 08:00:12
Documents
2
Period of Report
2022-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 EX-24 DOCUMENT attachment1.htm EX-24 4585
  Complete submission text file 0000899243-22-028198.txt   7655
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065
Business Address
Nabel Gary J. (Reporting) CIK: 0001867450 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40629 | Film No.: 221150448